KR20010034728A - 덱스메데토미딘의 중환자실 진정 용도 - Google Patents
덱스메데토미딘의 중환자실 진정 용도 Download PDFInfo
- Publication number
- KR20010034728A KR20010034728A KR1020007010991A KR20007010991A KR20010034728A KR 20010034728 A KR20010034728 A KR 20010034728A KR 1020007010991 A KR1020007010991 A KR 1020007010991A KR 20007010991 A KR20007010991 A KR 20007010991A KR 20010034728 A KR20010034728 A KR 20010034728A
- Authority
- KR
- South Korea
- Prior art keywords
- dexmedetomidine
- patient
- dose
- microgram
- intensive care
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (37)
- 중환자실 환자 진정에 사용되는 약제를 생산하는 데 있어서 덱스메데토미딘 또는 그 약학적으로 허용되는 염의 용도.
- 제 1항에서, 덱스메데토미딘 또는 그 약학적으로 허용되는 염이 단독의 활성 약물이거나 실질적으로 단독의 활성 약물인 용도.
- 제 1항 또는 2항에서, 덱스메데토미딘 또는 약학적으로 허용되는 그 염을 플라스마 농도 0.1~2ng/ml를 달성하도록 하는 양으로 투여하는 용도.
- 제 3항에서, 덱스메데토미딘 또는 그 염을 정맥내 투여하는 용도.
- 제 4항에서, 덱스메데토미딘을 증량 투여량과 유지 투여량으로 투여하는 용도.
- 제 5항에서, 상기 증량 투여량과 유지 투여량을 인간에게 투여하는 용도.
- 제 6항에서, 덱스메테도미딘의 증량 투여량이 0.2~2마이크로그람/kg인 용도.
- 제 7항에서, 증량 투여량을 약 10분간 투여하는 용도.
- 제 8항에서, 덱스메데토미딘의 증량 투여량이 1마이크로그람/kg인 용도.
- 제 6항에서, 덱스메데토미딘의 유지 투여량이 0.1~2.0마이크로그람/kg/h인 용도.
- 제 10항에서, 덱스메데토미딘의 유지 투여량이 0.2~0.7마이크로그람/kg/h인 용도.
- 제 11항에서, 덱스메데토미딘의 유지 투여량이 0.4~0.7마이크로그람/kg/h인 용도.
- 중환자실 환자를 진정시키는 방법에서, 상기 방법이 덱스메데토미딘 또는 그 약학적으로 허용되는 염을 환자에게 투여하는 것을 포함하는 방법.
- 제 13항에서, 덱스메데토미딘 또는 그 약학적으로 허용되는 염이 단독 활성 약물이거나, 실질적으로 단독 활성 약물인 방법.
- 약학적 조성물을 환자에게 투여하는 것을 포함하는 중환자실 환자를 진정시키는 방법에서, 상기 약학적 조성물이 활성 약물과 불활성 물질을 포함하며 상기 활성 약물이 덱스메데토미딘 또는 약학적으로 허용되는 그 염으로 이루어지는 방법.
- 제 13, 14 또는 15항에서, 덱스메데토미딘 또는 약학적으로 허용되는 그 염을 플라스마 농도 0.1~2ng/ml를 달성하도록 하는 양으로 투여하는 방법.
- 제 16항에서, 덱스메데토미딘 또는 약학적으로 허용되는 그 염을 정맥내 투여하는 방법.
- 제 17항에서, 덱스메데토미딘을 증량 투여량과 유지 투여량으로 투여하는 방법.
- 제 18항에서, 환자가 인간인 방법.
- 제 19항에서, 덱스메데토미딘의 증량 투여량이 0.2~2마이크로그람/kg인 방법.
- 제 20항에서, 증량 투여랑을 10분간 투여하는 방법.
- 제 21항에서, 덱스메데토미딘의 증량 투여량이 1마이크로그람/kg인 방법.
- 제 19항에서, 덱스메데토미딘의 유지 투여량이 0.1~2.0마이크로그람/kg/h인 방법.
- 제 23항에서, 유지 투여량이 0.2~0.7마이크로그람/kg/h인 용도.
- 제 24항에서, 유지 투여량이 0.4~0.7마이크로그람/kg/h인 용도.
- 중환자실 진정에 있어서 덱스메데토미딘 또는 약학적으로 허용되는 그 염의 용도.
- 제 26항에서, 덱스메데토미딘 또는 그 약학적으로 허용되는 염이 단독 활성 약물이거나 또는 실질적으로 단독 활성 약물인 용도.
- 제 26항 또는 27항에서, 덱스메데토미딘 또는 약학적으로 허용되는 염을 플라스마 농도 0.1~2ng/ml에 도달하도록 하는 양으로 투여하는 용도.
- 제 28항에서, 덱스메데토미딘 또는 그 약학적으로 허용되는 염을 정맥내 투여하는 용도.
- 제 29항에서, 덱스메데토미딘을 증량 투여량과 유지 투여량으로 투여하는 용도.
- 제 30항에서, 증량 투여량 및 유지 투여량을 인간에게 투여하는 용도.
- 제 31항에서, 덱스메데토미딘의 증량 투여량이 0.2~2마이크로그람/kg인 용도.
- 제 32항에서, 상기 증량 투여량을 약 10분간 투여하는 용도.
- 제 33항에서, 덱스메데토미딘의 증량 투여량이 1마이크로그람/kg인 용도.
- 제 31항에서, 덱스메데토미딘의 유지 투여량이 0.1~2.0마이크로그람/kg/h인 용도.
- 제 35항에서, 덱스메데토미딘의 유지 투여량이 0.2~0.7마이크로그람/kg/h인 용도.
- 제 36항에서, 덱스메데토미딘의 유지 투여량이 0.4~0.7마이크로그람/kg/h인 용도.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8028798P | 1998-04-01 | 1998-04-01 | |
US60/080,287 | 1998-04-01 | ||
US11094498P | 1998-12-04 | 1998-12-04 | |
US60/110,944 | 1998-12-04 | ||
PCT/FI1999/000266 WO1999049854A2 (en) | 1998-04-01 | 1999-03-31 | Use of dexmedetomidine for icu sedation |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010034728A true KR20010034728A (ko) | 2001-04-25 |
Family
ID=26763325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020007010991A KR20010034728A (ko) | 1998-04-01 | 1999-03-31 | 덱스메데토미딘의 중환자실 진정 용도 |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1069893B1 (ko) |
JP (1) | JP4606581B2 (ko) |
KR (1) | KR20010034728A (ko) |
CN (1) | CN1168441C (ko) |
AR (1) | AR015744A1 (ko) |
AT (1) | ATE347359T1 (ko) |
AU (1) | AU754484B2 (ko) |
BG (1) | BG64540B1 (ko) |
BR (1) | BR9909872A (ko) |
CA (1) | CA2326339C (ko) |
CZ (1) | CZ301013B6 (ko) |
DE (1) | DE69934305T2 (ko) |
DK (1) | DK1069893T3 (ko) |
EA (1) | EA005524B1 (ko) |
ES (1) | ES2278441T3 (ko) |
GB (1) | GB2352972B (ko) |
HU (1) | HU229162B1 (ko) |
IL (1) | IL138416A (ko) |
NO (1) | NO329194B1 (ko) |
NZ (1) | NZ507203A (ko) |
PL (1) | PL192517B1 (ko) |
PT (1) | PT1069893E (ko) |
SI (1) | SI1069893T1 (ko) |
SK (1) | SK286160B6 (ko) |
TR (1) | TR200002837T2 (ko) |
TW (1) | TW552136B (ko) |
WO (1) | WO1999049854A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150071027A (ko) * | 2012-10-15 | 2015-06-25 | 오리온 코포레이션 | 수의학적 소음 혐오증 완화 방법 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU778522B2 (en) | 1999-10-29 | 2004-12-09 | Orion Corporation | Treatment or prevention of hypotension and shock |
HUP0600241A2 (en) * | 2002-04-08 | 2006-07-28 | Mgi Gp | Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
US7141597B2 (en) * | 2003-09-12 | 2006-11-28 | Allergan, Inc. | Nonsedating α-2 agonists |
US20060058700A1 (en) * | 2004-08-26 | 2006-03-16 | Marro Dominic P | Patient sedation monitor |
WO2008036858A2 (en) | 2006-09-20 | 2008-03-27 | The Board Of Regents Of The University Of Texas System | Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
PL2244737T3 (pl) | 2008-01-22 | 2020-05-18 | The Board Of Regents Of The University Of Texas System | Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu |
KR101859486B1 (ko) * | 2009-05-15 | 2018-06-28 | 레크로파마, 인코포레이티드 | 설하용 덱스메데토미딘 조성물과 그의 사용 방법 |
DE102009050016A1 (de) | 2009-05-27 | 2011-05-05 | Modine Manufacturing Co., Racine | Wärmeübertragereinheit |
US20130096170A1 (en) * | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
KR102190009B1 (ko) | 2011-12-11 | 2020-12-15 | 바우닥스 바이오, 인코포레이티드 | 비강내 덱스메데토미딘(dexmedetomidine) 조성물 및 그 사용방법 |
US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
JP5921928B2 (ja) * | 2012-03-28 | 2016-05-24 | テルモ株式会社 | 既希釈デクスメデトミジン製剤 |
SG11201510548VA (en) | 2013-07-24 | 2016-02-26 | Tech Ab I | Use of the enantiomer levomedetomidine as inhibitor for marine biofouling of surfaces |
TWI629066B (zh) * | 2013-10-07 | 2018-07-11 | 帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
EP3054930B1 (en) * | 2013-10-07 | 2020-12-02 | Teikoku Pharma USA, Inc. | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
EP3054932B1 (en) * | 2013-10-07 | 2020-12-09 | Teikoku Pharma USA, Inc. | Dexmedetomidine transdermal delivery devices and methods for using the same |
CN113975273B (zh) * | 2020-07-27 | 2023-07-11 | 宜昌人福药业有限责任公司 | 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
FI844786A0 (fi) * | 1984-12-04 | 1984-12-04 | Farmos Oy | Terapeutiskt utnyttjbar foerening. |
GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
US5344840A (en) * | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
GB2215206B (en) * | 1988-02-29 | 1991-07-03 | Farmos Oy | 4-substituted imidazole derivatives useful in perioperative care |
US5217718A (en) * | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
FI894911A0 (fi) * | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
GB2281206A (en) * | 1993-08-25 | 1995-03-01 | Orion Yhtymae Oy | Use of dexmedetomidine |
-
1999
- 1999-03-30 AR ARP990101414A patent/AR015744A1/es unknown
- 1999-03-31 SI SI9930941T patent/SI1069893T1/sl unknown
- 1999-03-31 AU AU31494/99A patent/AU754484B2/en not_active Expired
- 1999-03-31 PT PT99913332T patent/PT1069893E/pt unknown
- 1999-03-31 EP EP99913332A patent/EP1069893B1/en not_active Expired - Lifetime
- 1999-03-31 ES ES99913332T patent/ES2278441T3/es not_active Expired - Lifetime
- 1999-03-31 GB GB0024932A patent/GB2352972B/en not_active Expired - Lifetime
- 1999-03-31 DK DK99913332T patent/DK1069893T3/da active
- 1999-03-31 PL PL343553A patent/PL192517B1/pl unknown
- 1999-03-31 EA EA200001010A patent/EA005524B1/ru not_active IP Right Cessation
- 1999-03-31 IL IL13841699A patent/IL138416A/xx not_active IP Right Cessation
- 1999-03-31 TR TR2000/02837T patent/TR200002837T2/xx unknown
- 1999-03-31 CA CA002326339A patent/CA2326339C/en not_active Expired - Lifetime
- 1999-03-31 NZ NZ507203A patent/NZ507203A/xx not_active IP Right Cessation
- 1999-03-31 BR BRPI9909872-5A patent/BR9909872A/pt not_active Application Discontinuation
- 1999-03-31 KR KR1020007010991A patent/KR20010034728A/ko not_active Application Discontinuation
- 1999-03-31 HU HU0101498A patent/HU229162B1/hu unknown
- 1999-03-31 SK SK1436-2000A patent/SK286160B6/sk not_active IP Right Cessation
- 1999-03-31 JP JP2000540820A patent/JP4606581B2/ja not_active Expired - Lifetime
- 1999-03-31 AT AT99913332T patent/ATE347359T1/de active
- 1999-03-31 DE DE69934305T patent/DE69934305T2/de not_active Expired - Lifetime
- 1999-03-31 CN CNB998046272A patent/CN1168441C/zh not_active Ceased
- 1999-03-31 WO PCT/FI1999/000266 patent/WO1999049854A2/en active IP Right Grant
- 1999-03-31 CZ CZ20003484A patent/CZ301013B6/cs not_active IP Right Cessation
- 1999-04-01 TW TW088105188A patent/TW552136B/zh not_active IP Right Cessation
-
2000
- 2000-09-26 BG BG104797A patent/BG64540B1/bg unknown
- 2000-09-29 NO NO20004931A patent/NO329194B1/no not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150071027A (ko) * | 2012-10-15 | 2015-06-25 | 오리온 코포레이션 | 수의학적 소음 혐오증 완화 방법 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20010034728A (ko) | 덱스메데토미딘의 중환자실 진정 용도 | |
US6716867B1 (en) | Use of dexmedetomidine for ICU sedation | |
JP2002509880A5 (ko) | ||
Hellyer | Pain management | |
US20130123298A1 (en) | Pharmaceutical composition for the prevention of perioperative arterial hypotension in humans | |
MUIR III | 8 DRUGS USED TO TREAT PAIN | |
US6194466B1 (en) | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
Pekcan | How can better anaesthetic combinations be performed? A review of current knowledge | |
US6218395B1 (en) | Centrally-acting beta-blockers and serotonin-enhancers for the treatment of anxiety disorders and adjustment disorders with anxiety | |
Mamatha | Comparative Study Between Dexmedetomidine and Midazolam in Inducing Conscious Sedation in Patient Undergoing Cataract Surgery | |
RU2664693C1 (ru) | Способ предоперационной подготовки пациентов к офтальмологическим операциям | |
WO2023201390A1 (en) | Aqueous quetiapine solutions | |
Ramya | A Comparative Study Of Dexmedetomidine Versus Midazolam For Monitored Anaesthesia Care In Middle Ear Surgeries | |
GB2602123A (en) | Composition for procedural sedation and use thereof | |
FRH | Comparison of Intrathecal Dexmedetomidine and Buprenorphine as Adjuvant to Bupivacaine for Lower Limb Surgeries | |
Mazzaferro | Anesthesia and pain management of the critical patient final. | |
Pathmanathan | 10 Sedation and delirium | |
Simpson | Clinical impressions on the use of largactil at Shaughnessy Hospital | |
Landsman et al. | 7 Post-operative pain control in infants and children | |
WO2005074928A1 (ja) | 高血圧症治療薬 | |
Nandhini | Effect of Intravenous Dexmedetomidine on Prolonging Spinal Anesthesia: A Randomised Controlled Study | |
Hydrochloride | Bupivacaine Hydrochloride | |
Richards | Applied pharmacology pertaining to the trauma patient | |
Hellyer | PAIN IN THE VETERINARY ICU-AN OVERVIEW | |
Evans | Dexmedetomidine and Pediatric Emergence Agitation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20061221 Effective date: 20070830 Free format text: TRIAL NUMBER: 2006101011028; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20061221 Effective date: 20070830 |
|
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL Free format text: TRIAL NUMBER: 2007201009873; APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
N231 | Notification of change of applicant | ||
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20071005 Effective date: 20081119 Free format text: TRIAL NUMBER: 2007201009873; JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20071005 Effective date: 20081119 |
|
J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL Free format text: TRIAL NUMBER: 2008301005373; APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL |